Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs. [electronic resource]
Producer: 20180409Description: 401-409 p. digitalISSN:- 1938-0690
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- diagnosis
- DNA Mutational Analysis -- methods
- ErbB Receptors -- genetics
- Erlotinib Hydrochloride -- therapeutic use
- Female
- Guideline Adherence
- Humans
- Lung Neoplasms -- diagnosis
- Male
- Middle Aged
- Mutation -- genetics
- Survival Analysis
- United States
- United States Department of Veterans Affairs
- Veterans
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.